Evidence map›Paper›PMID 35037366›Full record

ReviewAging cell2022

Tissue engineering strategies to bioengineer the ageing skin phenotype in vitro.

Lydia Costello, Teresa Dicolandrea, Ryan Tasseff, Robert Isfort, Charlie Bascom, Thomas von Zglinicki, Stefan Przyborski

Abstract readReview
In one paragraph

Review in Aging cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lydia CostelloDepartment of Biosciences, Durham University, Durham, UK.ORCID 0000-0002-9370-0019
Teresa DicolandreaProcter and Gamble, Mason Business Center, Cincinnati, Ohio, USA.
Ryan TasseffProcter and Gamble, Mason Business Center, Cincinnati, Ohio, USA.
Robert IsfortProcter and Gamble, Mason Business Center, Cincinnati, Ohio, USA.
Charlie BascomProcter and Gamble, Mason Business Center, Cincinnati, Ohio, USA.
Thomas von ZglinickiInstitute for Cell and Molecular Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Stefan PrzyborskiDepartment of Biosciences, Durham University, Durham, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/K019260/1Biotechnology and Biological Sciences Research Council BB/M011186/1Biotechnology and Biological Sciences Research Council BB/S006710/1
6 · The paper itself

Abstract

Human skin ageing is a complex and heterogeneous process, which is influenced by genetically determined intrinsic factors and accelerated by cumulative exposure to extrinsic stressors. In the current world ageing demographic, there is a requirement for a bioengineered ageing skin model, to further the understanding of the intricate molecular mechanisms of skin ageing, and provide a distinct and biologically relevant platform for testing actives and formulations. There have been many recent advances in the development of skin models that recapitulate aspects of the ageing phenotype in vitro. This review encompasses the features of skin ageing, the molecular mechanisms that drive the ageing phenotype, and tissue engineering strategies that have been utilised to bioengineer ageing skin in vitro.

Indexed as

Skin AgingPhenotypeSkinTissue Engineeringageingbioengineered tissuehumanin vitromolecular biology of agingskin

Identifiers

PMID35037366
PMCPMC8844123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.